Literature DB >> 27423300

Alternative Payment Models in Radiology: The Legislative and Regulatory Roadmap for Reform.

Ezequiel Silva1, Geraldine B McGinty2, Danny R Hughes3, Richard Duszak4.   

Abstract

The Medicare Access and CHIP Reauthorization Act (MACRA) replaces the sustainable growth rate with a payment system based on the Merit-Based Incentive Payment System and incentives for alternative payment model participation. It is important that radiologists understand the statutory requirements of MACRA. This includes the nature of the Merit-Based Incentive Payment System composite performance score and its impact on payments. The timeline for MACRA implementation is fairly aggressive and includes a robust effort to define episode groups, which include radiologic services. A number of organizations, including the ACR, are commenting on the structure of MACRA-directed initiatives.
Copyright © 2016 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Center for Medicare and Medicaid Innovation (CMMI); Health Care Payment and Action Network (HCPLAN); Medicare Access and CHIP Reauthorization Act (MACRA); Merit-Based Incentive Payment System (MIPS); Physician Quality Reporting System (PQRS); alternative payment models (APMs); clinical practice quality improvement activities; episode groups; resource use

Mesh:

Year:  2016        PMID: 27423300     DOI: 10.1016/j.jacr.2016.05.023

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  2 in total

Review 1.  If Disney ran your pediatric radiology department: a different approach to improving the patient and family experience.

Authors:  Raymond W Sze; Chido D Vera; Laurie Hogan; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2019-03-29

2.  Radiology Reporting in the Era of Patient-Centered Care: How Can We Improve Readability?

Authors:  Siya Patil; Joseph H Yacoub; Xue Geng; Susan M Ascher; Ross W Filice
Journal:  J Digit Imaging       Date:  2021-03-19       Impact factor: 4.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.